Featured Posts
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs, rapid…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
Search Posts
Op-Eds
Infant Formula Ambush by Henry I. Miller
Self-styled public-health activists often pursue issues that are surrogates for their real agenda. One example is the continuing attack on infant formula. Activists'…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. CIVIL LIBERTIES The Senate Select Committee on Intelligence begins debate over whether to renew…
Op-Eds
Infant Formula Fanatics Should Stop Milking the Issue, by Henry Miller
Self-styled public health activists often pursue issues that are surrogates for their real agenda. One example is the continuing attack on infant formula. The…
Op-Eds
Kraft Nod to Gene-Splicing Provides Food for Thought
Full document available in pdf format.<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> Biotechnology applied to agriculture and…
Op-Eds
Give Nestlé a Break
Generally, the European left has no love for big American financial firms. But some Swiss shareholder activists have embraced the U.S.’s largest proxy-advisory service in…
Op-Eds
Misnamed Activists Are Thorns In Rose Of Agbiotech Foods
In a spin-dominated world where activists claim—often on the flimsiest of data—that this, that or the other thing causes cancer or threatens the…